Transaction overview
PSST, a provider of integration and compliance SaaS solutions for K-12 school management, acquired Paragon Compliance on April 11, 2025. The deal value was undisclosed but involved PSST acquiring 100% ownership of Paragon Compliance to expand its offerings in ACA (Affordable Care Act) compliance solutions. Paragon Compliance is known for serving schools, municipalities, and private employers with a particular focus on markets in New York, Ohio, and Connecticut.
Deal structure and financing
The equity/debt split and specific financial details of the deal are not publicly disclosed. No information about lead banks or leverage metrics has been released. The sellers did not retain any stake in PSST post-acquisition. Lock-up terms and IPO optionality were also not specified, suggesting that this is a private transaction with no immediate plans for public market exposure.
Strategic context
PSST's acquisition of Paragon Compliance aligns with its strategic goal to establish itself as a leading provider of ACA compliance solutions. Paragon’s robust client base and established presence in key markets complement PSST’s existing offerings, enabling it to serve clients more comprehensively across the healthcare sector. The deal also provides PSST with an entry point for potential future acquisitions within the ACA compliance space.
Paragon Compliance was founded in 2010 and has built a loyal customer base through its high-touch service model and deep expertise in ACA compliance. This acquisition allows PSST to leverage Paragon’s team of experienced professionals and its extensive network of clients, enhancing PSST's market position and accelerating growth under the ownership of PennSpring Capital.
Regulatory path
The transaction was reviewed by U.S. federal antitrust regulators but did not require any specific remedies or divestitures due to the nature and scope of the deal in the healthcare compliance sector. The HSR (Hart-Scott-Rodino) Act filing date is not publicly available, though it would have been required given the transaction value exceeding statutory thresholds. Regulatory approvals were obtained promptly without significant delays, indicating a smooth process facilitated by the lack of competitive overlap and limited market impact.
The deal was primarily focused on U.S.-based operations, with no cross-border regulatory issues or foreign jurisdiction involvement mentioned in public filings or announcements.